Skip to main content
Livermore
Livermore
ZHEN

Ultragenyx Pharmaceutical Inc.

RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001515673

In the last 90 days, Ultragenyx Pharmaceutical Inc. insiders filed 0 open-market purchases and 4 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $3.55B in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Ultragenyx Pharmaceutical Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of RARE: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders2702275+7
Shares79.9M203.7K88.2M+8.49M (+10.7%)
Value$3.73B$9.50M$3.63B−$93.9M (−2.5%)

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (47)

Institutions that held Ultragenyx Pharmaceutical Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to RARE in Q2 2024
InstitutionSharesValue% of portfolio
Frazier Life Sciences Management, L.P.425,000$17.5M0.82%
Cutter Capital Management, LP365,000$15.0M4.57%
D. E. Shaw & Co., Inc.203,442$8.36M0.01%
LMR Partners LLP145,000$5.96M0.13%
Monashee Investment Management LLC100,000$4.11M0.53%
Parkman Healthcare Partners LLC100,000$4.11M0.56%
Mirae Asset Global ETFs Holdings Ltd.92,824$3.82M0.01%
Alyeska Investment Group, L.P.70,000$2.88M0.02%
Altium Capital Management LP70,000$2.88M1.19%
Weiss Asset Management LP50,000$2.06M0.10%
Tudor Investment Corp Et Al34,563$1.42M0.02%
Campbell & CO Investment Adviser LLC33,868$1.39M0.12%
Clearline Capital LP32,961$1.35M0.12%
Jump Financial, LLC27,289$1.12M0.02%
S&CO Inc20,255$832.0K0.06%
Oak Ridge Investments LLC19,350$795.3K0.08%
Twinbeech Capital LP17,813$732.1K0.01%
SG Americas Securities, LLC15,898$653.0K0.00%
Capital Fund Management S.A.14,996$616.3K0.01%
Toroso Investments, LLC13,676$562.1K0.01%
Jefferies Financial Group Inc.10,250$421.3K0.01%
Pearl River Capital, LLC7,671$315.3K0.05%
Sandia Investment Management LP7,500$308.3K0.39%
Bank of Montreal6,137$259.2K0.00%
Vestmark Advisory Solutions, Inc.5,945$244.3K0.01%
NewEdge Wealth, LLC5,945$244.3K0.01%
HBK Investments L P5,000$205.5K0.00%
Captrust Financial Advisors4,983$204.8K0.00%
Bellevue Group AG4,000$164.4K0.00%
Corebridge Financial, Inc.1,736$71.3K0.00%
nVerses Capital, LLC800$32.9K0.02%
Groupama Asset Managment729$30.0K0.00%
New Millennium Group LLC200$8.22K0.01%
Itau Unibanco Holding S.A.168$6.91K0.00%
NBC Securities, Inc.159$6.00K0.00%
Bessemer Group Inc140$6.00K0.00%
Picton Mahoney Asset Management147$6.00K0.00%
SRS Capital Advisors, Inc.100$4.11K0.00%
Versant Capital Management, Inc78$3.21K0.00%
Jones Financial Companies LLLP38$1.56K0.00%
Cullen/Frost Bankers, Inc.36$1.48K0.00%
International Assets Investment Management, LLC35$1.44K0.00%
Larson Financial Group LLC17$6990.00%
Innealta Capital, LLC15$6170.00%
Caitlin John, LLC5$2060.00%
Proequities, Inc.3$1230.00%
Mather Group, LLC.2$930.00%

Sold out (40)

Institutions that held Ultragenyx Pharmaceutical Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of RARE in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Eventide Asset Management, LLC359,000$16.8M
Deep Track Capital, LP167,784$7.83M
Neuberger Berman Group LLC104,939$4.90M
Laurion Capital Management LP68,000$3.17M
Duality Advisers, LP39,977$1.87M
ExodusPoint Capital Management, LP38,025$1.77M
Balyasny Asset Management LLC28,743$1.34M
Point72 Hong Kong Ltd27,004$1.26M
Susquehanna Fundamental Investments, LLC23,005$1.07M
Cubist Systematic Strategies, LLC22,631$1.06M
Acuta Capital Partners, LLC20,000$933.8K
Ghost Tree Capital, LLC20,000$933.8K
Exome Asset Management LLC17,800$831.1K
HSBC Holdings PLC17,349$809.9K
Dynamic Technology Lab Private Ltd15,712$734.0K
Bayesian Capital Management, LP15,302$714.5K
Teachers Retirement System of the State of Kentucky14,792$691.0K
Axq Capital, LP14,600$681.7K
Quest Partners LLC11,522$538.0K
Brevan Howard Capital Management LP9,077$423.8K
Winton Group Ltd8,755$408.8K
HRT Financial LP7,869$367.0K
Gotham Asset Management, LLC7,478$349.1K
Savant Capital, LLC7,245$338.3K
Teza Capital Management LLC5,293$247.1K
Cornercap Investment Counsel Inc5,161$241.0K
Capstone Investment Advisors, LLC4,863$227.1K
Utah Retirement Systems4,300$200.8K
Point72 Asia (Singapore) Pte. Ltd.3,587$167.5K
Quarry LP2,500$116.7K
Catalyst Funds Management Pty Ltd1,400$65.4K
American International Group, Inc.1,311$61.2K
Qube Research & Technologies Ltd642$30.0K
Truvestments Capital LLC158$7.38K
Leonteq Securities AG124$5.79K
Sunbelt Securities, Inc.86$4.01K
First PREMIER Bank53$2.00K
Anfield Capital Management, LLC40$1.87K
Riggs Asset Managment Co. Inc.22$1.03K
CIBC Private Wealth Group, LLC19$892

Not filed for Q2 2024 yet (2)

Institutions that held Ultragenyx Pharmaceutical Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RARE in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Credit Suisse AG201,268$9.40M
Shell Asset Management Co2,386$98.0K